(S (NP (JJ Modern) (NN medicine)) (VP (VBZ requires) (NP (VBN generalised) (NNS approaches)) (PP (IN to) (NP (NP (DT the) (NN synthesis) (CC and) (NN integration)) (PP (IN of) (NP (JJ multimodal) (NNS data))))) (, ,) (ADVP (RB often) (PP (IN at) (NP (NP (JJ different) (JJ biological) (NNS scales)) (, ,) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (VP (VBN applied) (PP (IN to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NN evidence) (NNS structures))) (, ,) (PP (JJ such) (IN as) (NP (NP (JJ complex) (NN disease) (NNS analyses)) (CC and) (NP (JJ epidemiological) (NNS models))))))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (JJ current) (NNS methods)) (VP (VBP are) (ADVP (RB either)) (ADJP (JJ slow) (CC and) (JJ expensive)) (, ,) (CC or) (ADJP (JJ ineffective) (PP (IN due) (PP (IN to) (NP (DT the) (NN inability) (S (VP (TO to) (VP (VB model) (NP (NP (DT the) (JJ complex) (NNS relationships)) (PP (IN between) (NP (NP (NNS data) (NNS modes)) (SBAR (WHNP (WDT which)) (S (VP (VBP differ) (PP (IN in) (NP (NN scale) (CC and) (NN format))))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP address) (NP (DT these) (NNS issues)) (PP (IN by) (S (VP (VBG proposing) (NP (DT a) (JJ cross-modal) (NML (NML (JJ deep) (NN learning) (NN architecture)) (CC and) (NML (NN co-attention))) (NN mechanism)) (S (VP (TO to) (ADVP (RB accurately)) (VP (VB model) (NP (NP (DT the) (NNS relationships)) (PP (IN between) (NP (DT the) (JJ different) (NNS data) (NNS modes)))) (, ,) (SBAR (IN while) (FRAG (ADJP (JJ further)))) (S (VP (VBG reducing) (NP (NML (NN patient) (NN diagnosis)) (NN time))))))))))) (. .))
(S (NP (NP (VBG Differentiating) (NML (NML (NP (NNP Parkinson) (POS 's)) (NNP Disease)) (-LRB- -LRB-) (NML (NN PD)) (-RRB- -RRB-)) (NNS patients)) (PP (IN from) (NP (JJ healthy) (NNS patients)))) (VP (VBZ forms) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (DT the) (NN evaluation))))) (. .))
(S (NP (DT The) (NN model)) (VP (VBZ outperforms) (NP (DT the) (JJ previous) (ADJP (NN state) (HYPH -) (IN of) (HYPH -) (DT the) (HYPH -) (NN art)) (JJ unimodal) (NN analysis)) (PP (IN by) (NP (CD 2.35) (NN %))) (, ,) (SBAR (IN while) (S (ADVP (RB also)) (VP (VBG being) (ADJP (NP (QP (CD 53) (NN %) (JJR more)) (NN parameter)) (JJ efficient)) (PP (IN than) (NP (DT the) (NN industry) (JJ standard) (JJ cross-modal) (NN model))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP (NP (DT the) (NN evaluation)) (PP (IN of) (NP (DT the) (NN attention) (NNS coefficients)))) (VP (VBZ allows) (PP (IN for) (NP (JJ qualitative) (NNS insights))) (S (VP (TO to) (VP (VB be) (VP (VBN obtained)))))) (. .))
(S (PP (IN Through) (NP (NP (DT the) (NN coupling)) (PP (IN with) (NP (NN bioinformatics))))) (, ,) (NP (NP (DT a) (JJ novel) (NN link)) (PP (IN between) (NP (NP (DT the) (ADJP (NN interferon) (HYPH -) (NN gamma) (HYPH -) (VBN mediated)) (NN pathway)) (, ,) (NP (NN DNA) (NML (NN methylation) (CC and) (NN PD)))))) (VP (VBD was) (VP (VBN identified))) (. .))
(S (NP (PRP We)) (VP (VBP believe) (SBAR (IN that) (S (NP (PRP$ our) (NN approach)) (VP (VP (VBZ is) (ADJP (JJ general))) (CC and) (VP (MD could) (VP (VB optimise) (NP (NP (NP (DT the) (NN process)) (PP (IN of) (NP (JJ medical) (NN evidence) (NN synthesis)))) (CC and) (NP (NP (NN decision) (NN making)) (PP (IN in) (NP (DT an) (JJ actionable) (NN way))))))))))) (. .))
